Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Pancreatic cancer
2025 Standout
Renal cell carcinoma
2024 Standout
Works of Michael R. Folkert being referenced
Ablative Radiation Therapy in Oligometastatic Pancreatic Cancer to Delay Polyprogression, Limit Chemotherapy, and Improve Outcomes
2022
Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC).
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael R. Folkert | 916 | 503 | 666 | 503 | 113 | 1.8k | |
| Daniel R. Zwahlen | 856 | 592 | 440 | 353 | 98 | 1.7k | |
| Bradley R. Pieters | 885 | 920 | 500 | 342 | 96 | 1.7k | |
| Venkatesh Rangarajan | 1102 | 208 | 758 | 680 | 243 | 2.4k | |
| R. de Crevoisier | 762 | 517 | 703 | 617 | 91 | 1.8k | |
| Florian Sterzing | 1639 | 1104 | 1125 | 484 | 98 | 2.5k | |
| Fabiola Paiar | 994 | 463 | 469 | 678 | 146 | 2.6k | |
| Melvin A. Astrahan | 891 | 553 | 669 | 193 | 87 | 2.4k | |
| R.A. Valdés Olmos | 437 | 273 | 590 | 547 | 89 | 1.9k | |
| Bernard Dubray | 1594 | 1088 | 1383 | 404 | 115 | 3.0k | |
| Dimitri Lefkopoulos | 829 | 866 | 822 | 509 | 95 | 2.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...